Liposomal Doxorubicin Market Report 2024-2032: Innovative Liposomal Formulations Pave the Way for Safer and More Effective Cancer Treatments
November 07, 2024 08:04 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global liposomal...
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - Develop Comprehensive Care Protocols & Improve Access to Treatments
October 25, 2024 10:56 ET
|
Research and Markets
Dublin, Oct. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By...
$1.89 Bn Liposomal Doxorubicin Markets, 2024-2030: Focus on Doxil/Caelyx, Lipodox, and Myocet
September 30, 2024 05:50 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product, By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer), By...
Doxorubicin Industry Research Report 2024-2030
September 23, 2024 09:54 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin Market Size, Share & Trends Analysis Report By Drug Formulation (Lyophilized Powder, Doxorubicin Injection), By Application, By...
India Liver Cancer Therapeutics Research Report 2024-2030 Featuring Natco Pharma, Dr. Reddy's Laboratories, Intas Pharmaceuticals, Mylan Pharmaceuticals, Lupin, Biocon, and Hetero Labs
September 11, 2024 11:54 ET
|
Research and Markets
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "India Liver Cancer Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ...
Unresectable Hepatocellular Carcinoma: Global Market Forecast at $2.64 Billion by 2028, Dominated by Pfizer, Johnson & Johnson, Roche, Merck & Co, and Bayer
May 07, 2024 12:33 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Unresectable Hepatocellular Carcinoma Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global unresectable...
Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim
April 15, 2024 07:20 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Liver Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides...
Global Liver Cancer Drug Market to Reach USD 7.83 Billion by 2030: Innovative treatments like oncolytic viruses and RNA interference (RNAi) have gained market traction
April 10, 2024 04:04 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And...
Doxorubicin Global Strategic Research Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023, Driven by Rise in Cancer Incidence and Innovations in Cancer Drug Delivery
April 05, 2024 09:07 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Doxorubicin Market to Reach $1.7...
Nivolumab Market Forecasts Indicate Robust Growth Driven by Advances in Cancer Immunotherapy and Increased Global Access to Care
February 15, 2024 14:57 ET
|
Research and Markets
Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The "Nivolumab Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Recent advancements in cancer treatment and the...